← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 12, 2018Last known activity
Jan 27, 2026
Timeline
2010s
- Jun 1, 2017
Addpharma Inc.— Founded
Drugs by trial phase (50 distinct, 42 trials)
Phase 3 (18 own, 0 via acquisition)
Phase 1 (32 own, 0 via acquisition)
Indications
Recent trials (42)
- NCT07312799Lead sponsorPhase 1Jan 27, 2026
- NCT07312773Lead sponsorPhase 1Jan 23, 2026
- NCT07103278Lead sponsorPhase 1Dec 31, 2025
- NCT07152873Lead sponsorPhase 1Oct 20, 2025
- NCT06858865Lead sponsorPhase 1Jul 12, 2025
- NCT06976489Lead sponsorPhase 1May 31, 2025
- NCT06932705Lead sponsorPhase 1Apr 30, 2025
- NCT06916130Lead sponsorPhase 1Apr 21, 2025
- NCT06902818Lead sponsorPhase 1Mar 21, 2025
- NCT06884098Lead sponsorPhase 1Mar 10, 2025
- NCT06884085Lead sponsorPhase 1Feb 18, 2025
- NCT06747936Lead sponsorPhase 3Dec 31, 2024
- NCT06441630Lead sponsorPhase 3Sep 17, 2024
- NCT06348576Lead sponsorPhase 3May 20, 2024
- NCT06291207Lead sponsorPhase 3Apr 15, 2024
Details
- Founded
- Seoul, KR Jun 1, 2017
- Last known activity
- Jan 27, 2026